KND Kindred Healthcare Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Kindred Healthcare, Inc. to a Consortium is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--

The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Kindred Healthcare, Inc. (“Kindred Healthcare” or the “Company”) (NYSE: KND) stock prior to December 19, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Kindred Healthcare to a consortium composed of TPG Capital, Welsh, Carson, Anderson & Stowe, and Humana Inc. for $9 per share. To learn more about the action and your rights, go to:

http://www.zlk.com/mna/kindred-healthcare-inc

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The investigation concerns whether the Board of Kindred Healthcare breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether the Consortium is underpaying for Kindred Healthcare shares, thus unlawfully harming Kindred Healthcare shareholders.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
19/12/2017

Underlying

KNDKindred Healthcare Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kindred Healthcare Inc.

KND Kindred Healthc...

9 directors sold

Nine Directors at Kindred Healthcare Inc sold 886,006 shares at 9.000USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

KND KINDRED HEALTHCARE INC.
07/02/18 July 2, 2018 1 EN
KND Kindred Healthc...

Kindred Healthcare, Inc. - March 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

KND KINDRED HEALTHCARE INC.
05/31/18 May 31, 2018 2 EN
 PRESS RELEASE
Free
KND Kindred Healthc...

Kindred Stockholders Approve Transaction with TPG Capital, Welsh, Cars...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that at its special meeting of stockholders, stockholders approved the transaction with affiliates of TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. (NYSE:HUM) (together, the “consortium”). The final vote results will be reported on a Form 8-K filed with the Securities and Exchange Commission. Benjamin A. Breier, President and Chief Executive Officer of Kindred, said, “We are pleased that the trans...

April 5, 2018 1 EN
 PRESS RELEASE
Free
KND Kindred Healthc...

Brigade Corrects Inaccuracies in Kindred Healthcare’s (KND) Press Re...

NEW YORK--(BUSINESS WIRE)-- Brigade Capital Management, LP (“Brigade”), on behalf of funds managed by it, today responded to yesterday’s press release by Kindred Healthcare, Inc. (NYSE: KND) (“Kindred” or the “Company”) to correct what Brigade views as misleading statements by Kindred. Brigade believes Kindred’s shareholders deserve better and should vote “NO” to the proposed acquisition of the Company by a consortium of Humana, TPG Capital and Welsh, Carson, Anderson & Stowe. Kindred’s March 27, 2018 press release states tha...

March 28, 2018 1 EN
EUR 217.56
KND Kindred Healthc...

Kindred Healthcare, Inc.: Update to Credit Analysis

Kindred's credit profile is constrained by its high leverage and Medicare reimbursement risk. These risks are balanced by the company's good business diversity and large scale.

KND KINDRED HEALTHCARE INC.
03/27/18 March 27, 2018 11 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch